Menu

Recent Interviews

Lewis Black, CEO, Almonty Industries

Lewis Black
CEO | Almonty Industries
100 King Street West, M5X 1C7 Toronto (CAN)

info@almonty.com

+1 (647) 438-9766

Interview with mine operator Almonty Industries: "Tungsten makes e-cars better"


Nick Luksha, President, Prospect Ridge Resources

Nick Luksha
President | Prospect Ridge Resources
1288 West Cordova Street Suite 2807, V6C 3R3 Vancouver (CAN)

info@prospectridgeresources.com

Interview Prospect Ridge Resources: These fillets taste good to the market


Dirk Graszt, CEO, Clean Logistics SE

Dirk Graszt
CEO | Clean Logistics SE
Trettaustr.32, 21107 Hamburg (DE)

info@cleanlogistics.de

+49-4171-6791300

Interview Clean Logistics: Hydrogen challenge to Daimler + Co.


23. March 2020 | 15:00 CET

Aurora Cannabis, Bayer, EXMceuticals - ready for the time after Corona

  • Cannabis
Photo credits: pixabay.com

The cannabis hype was over and then came the corona crisis. Investors who believed in the active ingredient of cannabis and put money into the shares of companies in this industry are now likely to be sitting on a huge loss in most cases. It all started with the idea of a few companies to make one of the oldest medicinal plants in the world acceptable for general use within the framework of legalization. However, high margins and a large market soon led to competition and a brokerage industry was earning a lot of money - soon several hundred cannabis companies were listed on the stock exchange.

time to read: 1 minutes by Mario Hose
ISIN: CA05156X1087 , DE000BAY0017 , CA30207T1049


 

Author

Mario Hose

Born and raised in Hannover, Lower Saxony follows social and economic developments around the globe. As a passionate entrepreneur and columnist he explains and compares the most diverse business models as well as markets for interested stock traders.

About the author


Founder sells shares

One of the first major companies in this sector was Aurora Cannabis. During the boom phase in 2018, the shares changed hands at over CAD 16.00. On Friday, the company's shares closed on the home stock exchange in Toronto at 1.06 CAD. Aurora Cannabis is now worth only CAD 1.2 billion on the stock exchange. The price slide began in the first quarter of 2019 and has continued since then.

Last week the founder, Terry Booth, sold about 12,161,900 shares on the open market. Interim CEO Michael Singer explained that this transaction is related to the previously announced transition of Mr. Booth's role within Aurora Cannabis.

Bayer regains marketing rights

The German Bayer group is also present on the market for cannabis products. The company has been responsible for marketing Sativex under the product name Nabiximole in the United Kingdom since 2010. However, Bayer and GW Pharmaceuticals recently announced that the German group will return the marketing rights in 2020. Nabiximole can be used in the treatment of spasticity due to multiple sclerosis.

In the future GW Pharmaceuticals will take over the marketing in the United Kingdom. The two companies are working together to ensure a 'seamless transition', according to a statement.

Team for growth is ready

The management of EXMceuticals focuses on building a supplier for the medical industry. In the future, the company wants to supply the European market with pure and high-quality extracts from the cannabis plant from Portugal. CEO of EXMceuticals is Jonathan Summers. As a former manager at Goldman Sachs, he has filled the former shell company with experts in the past months, see the corresponding press releases.

In the current market environment, with all the curfews in Europe, the company is in a kind of waiting loop. As soon as the corona crisis is over, EXMceuticals should return to the focus of investors. With a share price of CAD 0.265, the company is worth only CAD 10 million on the stock market. In July 2019, the EXMceuticals share was still trading at over CAD 1.70. Stock market wisdom says: In times of crisis the foundation for future wealth is laid.


Author

Mario Hose

Born and raised in Hannover, Lower Saxony follows social and economic developments around the globe. As a passionate entrepreneur and columnist he explains and compares the most diverse business models as well as markets for interested stock traders.

About the author



Conflict of interest & risk note

In accordance with §34b WpHG we would like to point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH may hold long or short positions in the aforementioned companies and that there may therefore be a conflict of interest. Apaton Finance GmbH may have a paid contractual relationship with the company, which is reported on in the context of the Apaton Finance GmbH Internet offer as well as in the social media, on partner sites or in e-mail messages. Further details can be found in our Conflict of Interest & Risk Disclosure.


Related comments:

19. November 2021 | 13:13 CET | by Carsten Mainitz

Sativa Wellness Group, Aurora Cannabis, TUI - Rising consumer spending on wellness and travel

  • Cannabis

According to Statista, the health and wellness market is worth around EUR 105 billion. More than USD 900 billion is spent annually worldwide on beauty and antiaging alone. Spending on travel is also increasing significantly after a sharp drop in the wake of the Corona pandemic. Reason enough to take a look at three stocks of industry representatives. Who is making the running?

Read

11. November 2021 | 13:02 CET | by Fabian Lorenz

Bayer, TUI, Sativa Wellness: Figures move share prices

  • Cannabis

The reporting season is drawing to a close. Overall, most companies have been convincing, and the stock markets have been very friendly in recent weeks. Bayer published positive quarterly figures, raised its forecast for the full year and thus convinced the analysts from DZ Bank. Sativa Wellness benefits from the boom around cannabis and CBD. The still-new boom is growing strongly and is already in the black. At TUI, the operating figures play less of a role. The development of the Corona figures and, thus, possible travel restrictions in the coming winter are more critical. Read more about all three shares here.

Read

28. October 2021 | 12:04 CET | by André Will-Laudien

Canopy, Tilray, Sativa Wellness, Formycon - Finding the next cannabis rocket!

  • Cannabis

The big bull market in cannabis ran through 2018 and 2019, and then in 2020, the reality set in that only a fraction of states around the world will implement general licensing for hemp. The newly elected federal parliament has its first constituent session these days. Climate change and investments in digital infrastructure are two of the most important topics in the coalition negotiations to form a new federal government. One topic that is not quite so high on the list of priorities, but is already causing a lot of excitement in the run-up, is the possible legalization of cannabis. The Greens and FDP have been advocating legal, regulated trade for some time. Of course, nothing has been decided yet, but the outgoing federal government's drug commissioner, Daniela Ludwig of the CSU, already warns of the consequences. We take a look at important industry representatives.

Read